What is Uniqure NV (QURE) stock price today?

Uniqure NV (QURE) currently trades at $16.73 per share. The stock has a market capitalization of $1.05B and a P/E ratio of —x.

Is QURE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Uniqure NV has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Uniqure NV's revenue and earnings?

Uniqure NV has trailing twelve-month (TTM) revenue of $16.10M with profit margins of 0.00%. Earnings per share (EPS) is $-3.46.

QURE

Uniqure NV

NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY

$16.73

-7.31% today

Updated 2026-04-29

Market cap

$1.05B

P/E ratio

—

P/S ratio

65.51x

EPS (TTM)

$-3.46

Dividend yield

—

52W range

$9 – $72

Volume

3.4M

Market cap

$1.05B

P/E ratio

—

P/S ratio

65.51x

EPS (TTM)

$-3.46

Dividend yield

—

52W range

$9 – $72

Volume

3.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$38.29

+128.87%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-77.89M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$106.48M	$15.84M	$27.12M	$16.10M	$16.10M
Net income	$-126.79M	$-308.48M	$-239.56M	$-198.97M	$-37.09M
EPS	—	—	—	—	$-3.46
Free cash flow	$-162.75M	$-153.08M	$-186.10M	$-178.40M	$-77.89M
Profit margin	-119.07%	-1,947.09%	-883.35%	-1,236.00%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
QURE	$1.05B	22	3.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Uniqure NV trades at $16.73. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $16.10M.

Frequently asked questions

What is Uniqure NV's stock price?

Uniqure NV (QURE) trades at $16.73.

Is Uniqure NV overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Uniqure NV (QURE)?

The analyst target price is $38.29, representing +128.9% upside from the current price of $16.73.

What is Uniqure NV's revenue?

TTM revenue is $16.10M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio65.51x

ROE-207.10%

Beta0.75

50D MA$16.96

200D MA$25.40

Shares out0.06B

Float0.05B

Short ratio—

Avg volume3.4M

Performance

1 week+8.27%

1 month+87.04%

3 months-29.42%

YTD-29.42%

1 year—

3 years—

5 years—

Compare

QURE vs LLY →QURE vs JNJ →QURE vs ABBV →Stock screener →